Type 1 Diabetes Trial, Recruiting NCT05203640 Sponsor: University of Alberta Condition: Type 1 Diabetes
Back to Type 1 Diabetes

Type 1 Diabetes Trial, Recruiting

NCT05203640
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Women who have been diagnosed with type 1 diabetes for at least one year
  • People whose last menstrual period was at least 12 months ago (i.e., have gone through menopause)
  • People who are physically able and willing to do resistance exercise (such as weight training)
  • People whose HbA1c (a measure of average blood sugar over several months) is below 10%
  • People who live near Edmonton, Alberta, or are able to travel to the University of Alberta for in-person sessions

Who may not be able to join:

  • People whose HbA1c is above 9.9%
  • People who experience frequent and unpredictable low blood sugar episodes
  • People who have changed their insulin management approach within the two months before the study
  • People with blood pressure higher than 144/95
  • People with severe nerve damage in their hands or feet (confirm with trial site)
  • People with a history of heart disease or other cardiovascular conditions
  • People with injuries to muscles, bones, or joints that would affect their ability to do resistance exercise
  • People who take medications other than insulin that affect blood sugar levels — for example, certain antipsychotic medications or steroid-based medicines
  • People with a body mass index (BMI) over 30 kg/m²
  • People who smoke
  • People who drink more than two alcoholic drinks per day on average

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 780-679-1688

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 April 2022
Est. completion
30 June 2026

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Blood glucose

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov